EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Antibody‐Microbiota Interface in Autoimmune Diseases

Solène Puechberty, Delphine Sterlin

Muscle & Nerve · 2026

DOI: 10.1002/mus.70131 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Muscle & Nerve, 2026. Verfasst von Solène Puechberty und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Inserm, CNRS, Paris, France. Hauptthemen laut MEDLINE: Autoimmune Diseases, Microbiota, Autoantibodies, Gastrointestinal Microbiome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 188 Literaturangaben. Gefördert von: Assistance Publique - Hôpitaux de Paris.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human intestine harbors a dense community of commensal microbes that strongly shape humoral immune responses. While secretory immunoglobulin A (sIgA) has long been recognized as a key regulator of microbiota compartmentalization and intestinal homeostasis, recent studies have also highlighted important roles for secretory IgM and systemic IgG in host–microbiota interactions. In this review, we examine critical aspects of the antibody–microbiota interface, first showing the extent to which microbiota and factors influencing microbiota ecosystem such as diet shape sIgA repertoire and binding capacity. We further integrate insights from both murine and human studies to provide a comprehensive overview of how antibody–microbiota interactions are altered in autoimmune diseases and contribute both to the identification of microbial drivers of disease and to the development of new therapeutic approaches. It is noteworthy that myasthenia gravis (MG) patients have a unique microbial signature, different from other autoimmune diseases, suggesting that yet‐to‐be‐identified gut bacteria might specifically drive the host's immune response toward MG. Finally, we discuss the mechanisms through which the microbiota may contribute to the initiation or perpetuation of dysregulated immune responses underlying autoimmunity. Given the presence of IgA autoantibodies in MG patients and the broad homology between the acetylcholine receptor and the microbial proteome, molecular mimicry and epitope spreading should be investigated as potential triggering mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune DiseasesMicrobiotaAutoantibodiesGastrointestinal MicrobiomeHumansAnimalsImmunoglobulin A, Secretory

Stichwörter der Autor:innen

antibodyautoimmunityepitope spreadingmicrobiotamolecular mimicryneoepitopes

Substanzen

AutoantibodiesImmunoglobulin A, Secretory

Autor:innen und Institutionen

  • Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Inserm, CNRS, Paris, France.
  • Département d'Immunologie, Hôpital La Pitié-Salpêtrière, AP-HP, Sorbonne Université, Paris, France.

Förderung

  • Assistance Publique - Hôpitaux de Paris

Zitieren

APA

Puechberty, S., & Sterlin, D. (2026). The Antibody‐Microbiota Interface in Autoimmune Diseases. Muscle & Nerve. https://doi.org/10.1002/mus.70131

Vancouver

Puechberty S, Sterlin D. The Antibody‐Microbiota Interface in Autoimmune Diseases. Muscle & Nerve. 2026. doi:10.1002/mus.70131

BibTeX
@article{Puechberty2026,
  author = {Puechberty, Solène and Sterlin, Delphine},
  title = {The Antibody‐Microbiota Interface in Autoimmune Diseases},
  journal = {Muscle & Nerve},
  year = {2026},
  doi = {10.1002/mus.70131}
}
Kostenlos starten →